新型双通道LMA®Gastro™喉罩用于上消化道内镜的有效性:前瞻性观察研究
这项前瞻性、开放标签、观察性研究纳入292例ASA 1-2级、低误吸风险接受上消化道内镜的患者,在丙泊酚静脉麻醉下标准化置入新型双通道LMA®Gastro™喉罩。按方案分析(n=290)内镜成功率99%(95%CI 98-100),喉罩置入成功率99%(95%CI 98-100),术中最低氧饱和度中位数98%(IQR 98-99),仅发生1例严重不良事件。结论认为该喉罩在上消化道内镜临床使用中有效。
要点
- 喉罩置入成功率99%(95%CI 98-100),内镜成功率99%(95%CI 98-100)。
- 术中最低氧饱和度中位数98%(IQR 98-99),气道安全性较好。
- 仅1例严重不良事件(因咽痛和无法耐受液体再入院),总体耐受性良好。
核心结论
- LMA®Gastro™喉罩在上消化道内镜临床使用中显示有效。
研究设计与样本
- 前瞻性、开放标签、观察性研究,纳入292例ASA 1-2级、低误吸风险接受上消化道内镜的患者,采用丙泊酚静脉麻醉和标准化喉罩置入。
主要发现
- 按方案分析(n=290)中,喉罩置入成功者的内镜成功率为99%(95%CI 98-100)。
- 喉罩置入成功率(n=292)为99%(95%CI 98-100),其95%CI下限至少98%,表明有效。
- 术中最低氧饱和度中位数(IQR)为98%(98-99)。
- 仅发生1例严重不良事件(因咽痛和无法耐受液体再入院),已报告伦理委员会。
关键数值与推荐
- 内镜成功率和喉罩置入成功率的95%CI下限均至少98%,作为有效性判断标准。
临床怎么用
- 对于ASA 1-2级、低误吸风险的上消化道内镜患者,可考虑使用LMA®Gastro™喉罩进行气道管理。
局限性
- 本研究为观察性设计,非随机对照,无法直接比较其他气道管理方式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Significant cardiorespiratory events are frequent in patients undergoing gastrointestinal endoscopy. Central to the occurrence of respiratory events is an unsecured airway. This study sought to determine the efficacy of a new laryngeal mask airway, the LMA®GastroTM Airway (Teleflex Medical, Athlone, Ireland), in patients undergoing upper gastrointestinal endoscopy. New design features include a dedicated channel for oesophageal intubation and separate channel with terminal cuff for lung ventilation. METHODS: In a prospective, open label, observational study, 292 ASA physical status classification 1 and 2 patients at low risk of pulmonary aspiration undergoing upper gastrointestinal endoscopy received i.v. propofol anaesthesia and standardized insertion of the LMA®GastroTM Airway. Endoscopy outcomes included insertion success, first attempt success, and ease of endoscope insertion. LMA®GastroTM Airway outcomes included insertion success, first attempt success, ease of insertion, lowest oxygen saturation, airway compromise, laryngospasm, bloodstained device, and sore throat. RESULTS: Per protocol analysis (n=290), the endoscopy success rate amongst the cohort with successful LMA®GastroTM Airway insertion was 99% [95% confidence interval (CI): 98, 100]. LMA®GastroTM Airway insertion success rate (n=292) was 99% (95% CI: 98, 100). For endoscopy and LMA®GastroTM Airway insertion success, the lower limit of the 95% CIs was at least 98%, indicating LMA®GastroTM Airway efficacy. Median (inter-quartile range) lowest intraoperative oxygen saturation was 98% (98, 99). Only one serious adverse event occurred (re-admission for sore throat and inability to tolerate fluids) and was reported to the Tasmanian Health and Medical Human Research Ethics Committee. CONCLUSIONS: The LMA®GastroTM Airway appears effective for clinical use in upper gastrointestinal endoscopy. CLINICAL TRIAL REGISTRATION: ACTRN12616001464459.
引用
- Terblanche NCS, Middleton C, Choi-Lundberg DL, et al. Efficacy of a new dual channel laryngeal mask airway, the LMA®Gastro™ Airway, for upper gastrointestinal endoscopy: a prospective observational study. Br J Anaesth. 2017. PMID: 29406183. doi:10.1016/j.bja.2017.11.075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。